RxDoctor Payments Data

Carole Ann Church

Family · Boone, NCNPI 1952917734

Payments from drug & device makers

$1,652in general payments, 2019–2025

Across 84 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$412
  • Gilead$243
  • GSK$170
  • Lilly USA, LLC$150
  • Indivior Inc.$78
  • Novo Nordisk$68
  • plus $531 from 17 others

What the payments were for

  • Food & beverage$1,62398%
  • Education$161%
  • Entertainment$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,652 in reported general payments places this provider in the 80th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$904
Medicare patients
14
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$25,601
EliquisApixaban17$16,914
OzempicSemaglutide13$12,346
JardianceEmpagliflozin15$11,678
Albuterol Sulfate HfaAlbuterol Sulfate61$2,138
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl39$1,819
Gabapentin49$859
Levothyroxine Sodium38$688
Ondansetron Hcl12$582
Atorvastatin Calcium56$449
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$442
Pantoprazole Sodium40$401
Rosuvastatin Calcium30$351
Sertraline Hcl21$341
Tizanidine Hcl16$336

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$170$25,60135 claims
Novo NordiskOzempic$68$12,34613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,522 family providers in North Carolina.

Other family in Boone

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →